ARYVX
Price
$15.46
Change
+$0.27 (+1.78%)
Updated
Jul 24 closing price
Net Assets
834.72M
CSFZX
Price
$60.97
Change
+$1.09 (+1.82%)
Updated
Jul 24 closing price
Net Assets
2.31B
Interact to see
Advertisement

ARYVX vs CSFZX

ARYVX vs CSFZX Comparison Chart in %
View a ticker or compare two or three
VS
ARYVX vs. CSFZX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARYVX is a Buy and CSFZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 2.31B vs. ARYVX (835M). CSFZX pays higher dividends than ARYVX: CSFZX (3.24) vs ARYVX (2.73). ARYVX was incepted earlier than CSFZX: ARYVX (15 years) vs CSFZX (12 years). ARYVX (1.11) is less costly to investors than CSFZX (0.84). ARYVX is a more actively managed with annual turnover of: 137.00 vs. CSFZX (57.00). CSFZX has a lower initial minimum investment than ARYVX: CSFZX (0) vs ARYVX (2500). ARYVX annual gain was more profitable for investors over the last year : 18.68 vs. CSFZX (15.02). ARYVX return over 5 years is better than : 12.37 vs. CSFZX (11.32).
ARYVXCSFZXARYVX / CSFZX
Total Expense Ratio1.110.84132%
Annual Report Gross Expense Ratio1.110.84132%
Fund Existence15 years12 years-
Gain YTD15.63213.393117%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets835M2.31B36%
Annual Yield % from dividends2.733.2484%
Returns for 1 year18.6815.02124%
Returns for 3 years39.0330.41128%
Returns for 5 years12.3711.32109%
Returns for 10 years63.2354.32116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GWGIX22.510.03
+0.13%
AMG GW&K Small Mid Cap Core I
WEUSX15.37-0.02
-0.13%
SEI World Equity Ex-US A (SIIT)
FBTTX41.62-0.08
-0.19%
Fidelity Advisor Biotechnology M
FSEBX16.96-0.04
-0.24%
Fidelity Advisor Sustainable U.S. Eq
PASIX10.49-0.03
-0.29%
PACE Alternative Strategies A